Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 29.3 USD 0.76% Market Closed
Market Cap: 14.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Baxter International Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Baxter International Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Baxter International Inc
NYSE:BAX
Tax Provision
-$304m
CAGR 3-Years
-19%
CAGR 5-Years
-2%
CAGR 10-Years
-6%
Becton Dickinson and Co
NYSE:BDX
Tax Provision
-$307m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Boston Scientific Corp
NYSE:BSX
Tax Provision
-$414m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Tax Provision
-$600m
CAGR 3-Years
-27%
CAGR 5-Years
-8%
CAGR 10-Years
-2%
Abbott Laboratories
NYSE:ABT
Tax Provision
-$1B
CAGR 3-Years
0%
CAGR 5-Years
-15%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Tax Provision
-$119.7m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
2%
No Stocks Found

Baxter International Inc
Glance View

Market Cap
14.9B USD
Industry
Health Care
Economic Moat
None

Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.

BAX Intrinsic Value
49.15 USD
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Baxter International Inc's Tax Provision?
Tax Provision
-304m USD

Based on the financial report for Sep 30, 2024, Baxter International Inc's Tax Provision amounts to -304m USD.

What is Baxter International Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-6%

The average annual Tax Provision growth rates for Baxter International Inc have been -19% over the past three years , -2% over the past five years , and -6% over the past ten years .

Back to Top